Attached files

file filename
EX-3.3 - EX-3.3 - AKCEA THERAPEUTICS, INC.a2231300zex-3_3.htm
EX-21.1 - EX-21.1 - AKCEA THERAPEUTICS, INC.a2231300zex-21_1.htm
EX-10.16 - EX-10.16 - AKCEA THERAPEUTICS, INC.a2231300zex-10_16.htm
EX-10.15 - EX-10.15 - AKCEA THERAPEUTICS, INC.a2231300zex-10_15.htm
EX-10.14 - EX-10.14 - AKCEA THERAPEUTICS, INC.a2231300zex-10_14.htm
EX-10.13 - EX-10.13 - AKCEA THERAPEUTICS, INC.a2231300zex-10_13.htm
EX-10.12 - EX-10.12 - AKCEA THERAPEUTICS, INC.a2231300zex-10_12.htm
EX-10.10 - EX-10.10 - AKCEA THERAPEUTICS, INC.a2231300zex-10_10.htm
EX-10.9 - EX-10.9 - AKCEA THERAPEUTICS, INC.a2231300zex-10_9.htm
EX-10.8 - EX-10.8 - AKCEA THERAPEUTICS, INC.a2231300zex-10_8.htm
EX-10.7 - EX-10.7 - AKCEA THERAPEUTICS, INC.a2231300zex-10_7.htm
EX-10.6 - EX-10.6 - AKCEA THERAPEUTICS, INC.a2231300zex-10_6.htm
EX-10.5 - EX-10.5 - AKCEA THERAPEUTICS, INC.a2231300zex-10_5.htm
EX-10.4 - EX-10.4 - AKCEA THERAPEUTICS, INC.a2231300zex-10_4.htm
EX-10.2 - EX-10.2 - AKCEA THERAPEUTICS, INC.a2231300zex-10_2.htm
EX-4.2 - EX-4.2 - AKCEA THERAPEUTICS, INC.a2231300zex-4_2.htm
EX-3.1 - EX-3.1 - AKCEA THERAPEUTICS, INC.a2231300zex-3_1.htm
EX-1.1 - EX-1.1 - AKCEA THERAPEUTICS, INC.a2231300zex-1_1.htm
S-1 - S-1 - AKCEA THERAPEUTICS, INC.a2231300zs-1.htm

QuickLinks -- Click here to rapidly navigate through this document


Exhibit 23.1

Consent of Independent Registered Public Accounting Firm

We consent to the reference to our firm under the caption "Experts" and to the use of our report dated March 27, 2017, in the Registration Statement (Form S-1) and related Prospectus of Akcea Therapeutics, Inc. dated March 27, 2017 for the registration of shares of its common stock.

    /s/ ERNST & YOUNG LLP
San Diego, California
March 27, 2017
   



QuickLinks

Consent of Independent Registered Public Accounting Firm